This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griggs, T. R. Articles by Brinkhous, K. M. Search for Related Content PubMed PubMed Citation Articles by Griggs, T. R. Articles by Brinkhous, K. M.

American Journal of Pathology, Vol 102, 137-145, Copyright © 1981 by American Society for Investigative Pathology

REGULAR ARTICLES

Susceptibility to atherosclerosis in aortas and coronary arteries of swine with von Willebrand's disease

TR Griggs, RL Reddick, D Sultzer and KM Brinkhous

The development of coronary and aortic atherosclerosis was determined after balloon catheter injury of coronary arteries and administration of an atherogenic diet in normal pigs and pigs that were homozygous and heterozygous for von Willebrand's disease. Coronary atherosclerosis developed to a similar degree in all three phenotypic groups. The mean intimal thickness at the site of maximal thickness in ballooned vessels was .51 mm in the normal pigs, .67 mm in carrier pigs, and .55 mm in bleeder pigs. The intimal thickness of non-ballooned vessels was .28 mm in normal pigs, .28 mm in carrier pigs, and .35 mm in bleeder pigs. Fibrous lesions of atherosclerosis covered an average of 3.88% of the aorta in normal pigs, 2.83% in carrier pigs, and 2.37% in bleeder pigs. The difference between the aortic lesions of normal animals and bleeders was significant (P less than .05). Absence of von Willebrand factor was associated with limited resistance to atherosclerosis in the aortas of experimental pigs but did not affect the development of atherosclerosis in either ballooned or nonballooned coronary arteries. These findings suggest, first, that von Willebrand factor function is not essential to the development of the atherosclerotic lesion in this model and, second, that the role of the von Willebrand factor in the development of atherosclerosis is complicated and appears to involve interaction with variables not yet defined.

This article has been cited by other articles:

				A. Sramek, P. Bucciarelli, A.B. Federici, P.M. Mannucci, V. De Rosa, G. Castaman, M. Morfini, M.G. Mazzucconi, A. Rocino, M. Schiavoni, et al. Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis: Results From a Multicenter Study in 47 Patients Circulation, February 17, 2004; 109(6): 740 - 744. [Abstract] [Full Text] [PDF]

				G. Theilmeier, C. Michiels, E. Spaepen, I. Vreys, D. Collen, J. Vermylen, and M. F. Hoylaerts Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia Blood, May 29, 2002; 99(12): 4486 - 4493. [Abstract] [Full Text] [PDF]

				N. Methia, P. Andre, C. V. Denis, M. Economopoulos, and D. D. Wagner Localized reduction of atherosclerosis in von Willebrand factor-deficient mice Blood, September 1, 2001; 98(5): 1424 - 1428. [Abstract] [Full Text] [PDF]

				F. Bilora, C. Dei Rossi, B. Girolami, A. Casonato, E. Zanon, A. Bertomoro, and A. Girolami Do Hemophilia A and von Willebrand Disease Protect Against Carotid Atherosclerosis? A Comparative Study Between . Coagulopathics and Normal Subjects by Means of Carotid Echo-Color Doppler Scan Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(4): 232 - 235. [Abstract] [PDF]

				A. Lafont and D. Faxon Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? Cardiovasc Res, July 1, 1998; 39(1): 50 - 59. [Full Text] [PDF]